Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance.

ABSTRACT:

SUBMITTER: Remington BC 

PROVIDER: S-EPMC9291584 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature